TipRanks
Go Ultimate55% OFF

Arbutus Biopharma (0SGC) Share Forecast & Price Target

See the Price Targets and Ratings of:All AnalystsTop AnalystsPremium

0SGC Analyst Ratings

There are no analyst ratings in the last 3 months.

0SGC Stock 12 Month Forecast

There are no analyst price targets in the last 3 months.

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for GB:0SGC
Analyst ProfileExpert FirmPrice TargetPositionUpside / DownsideActionDateFollowArticle
Jefferies$7buy110.97%UpsideReiterated12/11/25
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
AORTArtivion
MDWDMediwound
IMUXImmunic
RZLTRezolute
DFTXDefinium Therapeutics

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Arbutus Biopharma

3 Months
Dennis Ding
Dennis DingJefferies
Success Rate1/3 ratings generated profit
33%
Average Return
-7.67%

Copying Dennis Ding's trades and holding each position for 3 Months would result in 33.33% of your transactions generating a profit, with an average return of -7.67% per trade.

1 Year
Dennis Ding
Dennis DingJefferies
Success Rate1/3 ratings generated profit
33%
Average Return
-2.43%

Copying Dennis Ding's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of -2.43% per trade.

2 Years
Dennis Ding
Dennis DingJefferies
Success Rate1/3 ratings generated profit
33%
Average Return
+0.30%

Copying Dennis Ding's trades and holding each position for 2 Years would result in 33.33% of your transactions generating a profit, with an average return of +0.30% per trade.

0SGC Analyst Recommendation Trends

00.511.52Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Monthly rating counts for 0SGC
RatingMay 26Jun 26Jul 26Aug 26Sep 26
Strong Buy00000
Buy00000
Hold00000
Sell00000
Strong Sell00000
total00000

In the current month, 0SGC has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 0SGC average Analyst price target in the past 3 months is ―.

0SGC Financial Forecast

$-2$-1.25$-0.5$0.25$1Q4 2025Q2 2026Q3 2026
High$-0.02
Consensus$-0.02
Low$-0.02

0SGC Earnings Forecast

Next quarter’s earnings estimate for 0SGC is -$0.02 with a range of -$0.02 to -$0.02. The previous quarter’s EPS was -$0.03. 0SGC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0SGC has Performed in-line its overall industry.

$528,999$45.2M$89.8M$134.5M$179.1MQ4 2025Q2 2026Q3 2026
High$1M
Consensus$1M
Low$1M

0SGC Sales Forecast

Next quarter’s sales forecast for 0SGC is $1.00M with a range of $1.00M to $1.00M. The previous quarter’s sales results were $1.01M. 0SGC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0SGC has Performed in-line its overall industry.

0SGC Stock Forecast FAQ

Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
What do analysts say about Arbutus Biopharma?
Not enough analysts have published a price target to provide an average price target.
How can I buy shares of Arbutus Biopharma?
To buy shares of GB:0SGC, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.